Exodus Point Capital Management, LP Alkermes Plc. Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

A detailed history of Exodus Point Capital Management, LP transactions in Alkermes Plc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 219,610 shares of ALKS stock, worth $6.19 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

219,610

Previous 170,649 28.69%

Holding current value

$6.19 Million

Previous $4.11 Million 49.45%

% of portfolio

0.04%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$23.01 - $28.55 $1.13 Million - $1.4 Million	48,961 Added 28.69%	219,610 $6.15 Million
Q2 2024 Aug 13, 2024	BUY	$23.21 - $27.24 $3.96 Million - $4.65 Million	170,649 New	170,649 $4.11 Million
Q3 2023 Nov 09, 2023	BUY	$27.17 - $31.97 $1.76 Million - $2.07 Million	64,693 Added 175.06%	101,647 $2.85 Million
Q2 2023 Aug 10, 2023	SELL	$28.34 - $33.63 $3.47 Million - $4.12 Million	-122,502 Reduced 76.82%	36,954 $1.16 Million
Q1 2023 May 11, 2023	BUY	$25.31 - $29.02 $674,562 - $773,441	26,652 Added 20.07%	159,456 $4.5 Million
Q4 2022 Feb 13, 2023	BUY	$21.94 - $26.24 $620,331 - $741,909	28,274 Added 27.05%	132,804 $3.47 Million
Q3 2022 Nov 10, 2022	BUY	$22.0 - $31.87 $2 Million - $2.9 Million	90,922 Added 668.15%	104,530 $2.33 Million
Q2 2022 Aug 19, 2022	SELL	$26.4 - $30.54 $253,070 - $292,756	-9,586 Reduced 41.33%	13,608 $405,000
Q1 2022 May 13, 2022	BUY	$23.07 - $27.99 $535,085 - $649,200	23,194 New	23,194 $610,000
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $753,754 - $1.01 Million	-40,136 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $105,326 - $134,188	-5,784 Reduced 12.6%	40,136 $750,000
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $678,668 - $974,565	-44,098 Reduced 48.99%	45,920 $916,000
Q3 2020 Nov 16, 2020	BUY	$16.16 - $20.66 $1.45 Million - $1.86 Million	90,018 New	90,018 $1.49 Million
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $137,600 - $223,784	-10,536 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$17.29 - $21.74 $40,873 - $51,393	-2,364 Reduced 18.33%	10,536 $215,000
Q3 2019 Nov 14, 2019	BUY	$19.51 - $24.28 $251,679 - $313,212	12,900 New	12,900 $252,000

Others Institutions Holding ALKS

# of Institutions

360

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.63B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Alkermes Plc. Transaction History